LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Medacta Doubles Commitment to OREF!
Company News

Medacta Doubles Commitment to OREF!

April 4, 2017 2 min read Premium comments

Advertisement

Medacta Doubles Commitment to OREF!
(L to R): Michael L. Parks, MD., OREF president-elect; Eric Dremel, president, Medacta USA; Francesco Siccardi, executive vice president, Medacta International; Richard F. Santore, M.D., OREF trustee and chair of individual development; David G. Lewallen, M.D., president, OREF Board of Trustees. / Courtesy of Medacta International
Secondary

Medacta International, a family owned company headquartered in Castel San Pietro, Switzerland, has ramped up its partnership with the Orthopaedic Research and Education Foundation (OREF). While the two entities have worked together over the past two years, Medacta has now increased its support and will now match resident gifts two-to-one, up from its original commitment of one-to-one. According to the March 16, 2017, “…this program encourages residents to engage in charitable giving at an early state in their careers and prioritizes OREF as a beneficiary of their philanthropy.”

“Since the program started in 2015, the Medacta Challenge raised more than $150,000 for OREF. This includes contributions to OREF’s Research Fund from Francesco Siccardi, Executive Vice President of Medacta International, and Eric Dremel, President of Medacta USA, who each pledged $20,000 to kick off the partnership and demonstrate their commitment to the initiative. Mr. Siccardi and Mr. Dremel were recognized for their gifts as members of OREF’s Visionary Research Society.”

“We believe the next big innovation is always just around the corner and are excited that our expanded partnership with OREF will make already generous resident contributions even more impactful,” said Siccardi. “This partnership drives Medacta and OREF’s shared goal of providing the best possible care to improve the lives of patients around the globe.”

“OREF relies on the generosity of organizations like Medacta to continue supporting research in orthopaedics,” said OREF Board President David Lewallen, M.D. “The grants we provide enable innovators to push the envelope and be bold, effectively creating change in the orthopaedic discipline—ultimately providing patients with safer, better options, and a higher quality of life. None of this would be possible without our committed partners such as Medacta.”

Francesco Siccardi told OTW, “We’re excited that with our help, generous resident gifts to OREF will go three times further in providing critical funding to orthopedic investigators. We’re always looking for ways to help improve the patient experience, and this is just one more way we can do that.”

Dr. Lewallen commented to OTW, “During the first year of this expanded partnership, OREF will be focused on reaching as many residents as possible with the news that they can now triple the impact of their gift. Residents often believe that the $20, $50 or $100 gift they feel comfortable making isn’t large enough to make much of an impact. While we firmly believe that every gift helps, no matter the size, the increased match from Medacta gives us a great opportunity to engage those residents with the message that thanks to Medacta, their gift will have an even greater impact on our ability to fund orthopaedic research.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy